1.Source analysis and health risk assessment of polycyclic aromatic hydrocarbons in atmospheric PM2.5 in a district of Taizhou City from 2019 to 2021
Yanqiu ZHANG ; Guang YU ; Wei WANG ; Li HANG ; Qian WANG ; Li WANG ; Qiuju QIAO ; Jiuhong HUANG
Journal of Environmental and Occupational Medicine 2024;41(1):54-61
Background Polycyclic aromatic hydrocarbons (PAHs), one of the main components of fine particulate matter (PM2.5), have a certain impact on ambient air quality, and long-term exposure to PAHs may pose potential health risks to human beings. Objective To identify the distribution characteristics and sources of PAHs in atmospheric PM2.5 in a district of Taizhou City from 2019 to 2021, and to evaluate the health risks of PAHs to the population in the area through the inhalation pathway. Methods From 2019 to 2021, air PM2.5 sampling was carried out at a state-controlled surveillance point in a district of Taizhou City for 7 consecutive days on the 10th-16th of each month, the sampling time was 24 h·d−1, and the sampling flow rate was 100 L·min−1. PM2.5 mass concentration was calculated by gravimetric method. A total of 16 PAHs were determined by ultrasonic extraction-liquid chromatography. Kruskal-Wallis H test was used to compare the distribution charac teristics of PAHs concentrations by years and seasons, characteristic ratio and principal component analysis (PCA) was used to analyze their sources, and a lifetime carcinogenic risk (ILCR) model was used to assess the health risk of PAHs. Results From 2019 to 2021, the annual average concentrations [M (P25, P75)] of ∑PAHs in atmospheric PM2.5 in the selected district of Taizhou City were 6.52 (2.46, 10.59), 8.52 (4.56, 12.29), and 3.72 (1.51, 7.11) ng·m−3, respectively, and the annual benzo[a]pyrene (BaP) excess rates (national limit: 1 ng·m−3) were 27.38% (23/84), 47.62% (40/84), and 19.04% (16/84), respectively, both presenting 2020> 2019 > 2021 (P<0.001, P<0.05). The ∑PAHs concentration distribution showed a seasonal variation, with the highest value in winter and the lowest value in summer (P<0.05). Among the atmospheric PM2.5 samples, the proportion of 5-ring PAHs was the highest, the proportion of 2-3-ring PAHs was the lowest; the proportion of 2-4-ring PAHs showed a yearly upward trend, and the proportion of 5-6-ring PAHs showed yearly downward trend (P<0.05). The characteristic ratio and PCA results suggested that the sources of sampled PAHs were mainly mixed sources such as dust, fossil fuel (natural gas), coal combustion, industrial emissions, and motor vehicle exhaust emissions. The ILCR (RILCR) of PAHs by inhalation for men, women, and children were 1.83×10−6, 2.35×10−6, and 2.04×10−6, respectively, and the annual average RILCR was 2.07×10−6, all greater than 1×10−6. Conclusion For the sampled time period, the main sources of PAHs pollution in atmospheric PM2.5 in the target district of Taizhou City are dust, fossil fuel (natural gas), coal combustion, industrial emissions, motor vehicle emissions, etc., and PAHs may have a potential carcinogenic risk to local residents.
2.Study on Data Privacy-preserving Scheme in Internet Self-service Medical Diagnosis
Journal of Medical Informatics 2024;45(5):65-70
Purpose/Significance Aiming at the pain points that are easy to leak patient privacy in internet self-service medical di-agnosis,a set of secure data privacy protection scheme is designed to protect patients'medical and health data and provide accurate diag-nosis and treatment suggestions.Method/Process The disease data stored by the medical institutions and the patients'medical and health data are processed by homomorphic encryption and privacy protection control technology and uploaded to the cloud server.The cloud server calculates the similarity between the patients'medical and health data and the disease data of the medical institutions and matches the patients'disease condition to send the therapies to the patients.Result/Conclusion The medical data privacy protection scheme based on homomorphic encryption and privacy protection access control can effectively protect patients'privacy in internet self-service medical diagnosis,and provide accurate medical diagnosis and treatment recommendations.
3.Exploring the Value Evaluation Framework for High-Value Medical Consumables Access Management in China
Yingyao CHEN ; Yue XIAO ; Liping MA ; Chunlin JIN ; Qing LIU ; Jiaye LENG ; Jiuhong WU ; Libo TAO ; Haiyin WANG ; Minggang WANG ; Wudong GUO ; Li XIE ; Wenbo QI ; Yuanjin JI ; Kun ZHAO ; Shanlian HU
Chinese Health Economics 2023;42(12):3-8
Objective:To construct a value evaluation framework for high-value medical consumables,providing a guidance for medical insurance access and hospital access management scenarios in China.Methods:It conducted literature review,qualitative in-terviews and quantitative surveys.A total of 12 experts were invited for qualitative interviews,while 100 experts from four fields of health technology assessment,medical insurance,hospital management,and clinical practice participated in the quantitative survey.Through those process,it generated the composition of the value framework and the scoring of each item.Differences in ratings be-tween different scenarios and experts were analyzed through chi-square tests.The recommendation level for each item was graded.Re-sults:A comprehensive value evaluation framework for high-value medical consumables was established,which included 6 core dimen-sions,comprised 16 items for secondary dimensions and 50 items for tertiary dimensions.It showed significant differences between the medical insurance access and hospital access scenarios,as well as among different fields of experts in the same scenario.furthermore,grading the items in two scenarios.The medical insurance access scenario had 8 highly recommended items,and the hospital access scenario had 24 highly recommended items.Conclusion:Value evaluation should encourage multi-dimensional assessments and inter-disciplinary participation,continually improving the management of high-value medical consumables in medical insurance and hospital access.
5.Analysis on the construction and application of telemedicine system in Tibet Autonomous Region
Zhenjiang ZHANG ; Cheng DONG ; Fang PENG ; Jiuhong LIU ; Yongqiang MA ; Ruyi TIAN ; Li TIAN ; Wei SONG ; Meikui ZHANG
Chinese Journal of Hospital Administration 2021;37(4):289-292
Objective:To investigate the construction and application of telemedicine system in Tibet Autonomous Region.Methods:From June to July 2020, medical institutions at all levels in Tibet Autonomous Region were visited. Relevant information was collected through discussion, questionnaires and field visits, and the data of effective questionnaires were statistically analyzed.Results:A total of 125 medical institutions were visited, covering 7 regions of Tibet Autonomous Region, of which 74 medical institutions were able to realize audio-video two-way communication with the telemedicine platform of the PLA General Hospital. Seventy-three valid questionnaires were collected, and 64(88%)hospitals had software or hardware audio and video terminals. Twenty-five hospitals had never carried out remote consultation, accounting for 34%. The annual remote consultation amount of 35 hospitals was less than 10 cases, and that of 11 hospitals was 11-100 cases. Only 2 hospitals had carried out remote ECG and remote ultrasound diagnosis, with an annual consultation volume of more than 100 cases.Conclusions:The hospitals at or above the county level in Tibet Autonomous Region have established telemedicine system, but there are few remote services, the system idle rate is high, and the distance education resources are not matched.
6.Application of the logistic regression model for the analysis of accuracy related influencing factors on HPLC measurement of preservatives
Bin WANG ; Yao LI ; Ying ZHANG ; Jiuhong LI ; Xin ZHANG ; Xinyue CHEN ; Li MAO ; Kui LIU
Journal of Public Health and Preventive Medicine 2021;32(3):50-53
Objective To employ Logistic regression modeling to analyze the related factors influencing the accuracy of the high performance liquid chromatography (HPLC) determination of preservatives in beverages. Methods The HPLC separation was performed on a Zorbax Eclipse Plus C18 column with methanol-ammonium acetate solution as mobile phase. The external standard method was used to determine 5 beverage preservatives. The influencing factors on the measurement accuracy were statistically evaluated with univariate and multivariate analysis. Results Univariate analysis showed that the recovery rate of the added standard in the determination of coffee beverage preservatives by HPLC was affected by the pretreatment method, and the difference was statistically significant (P<0.05). Multivariate analysis showed that the main influencing factors on the accuracy of determination of sorbic acid was the pretreatment method (OR=5.406, P<0.05), while the sample type was a protective factor (OR=0.134, P<0.05). For the determination of benzoic acid, the main factor influencing the accuracy was the sample type (OR=1.112, P<0.05), while the pretreatment method was a protective factor (OR=0.447, P<0.05). Conclusion Logistic regression analysis can identify risk factors for the accuracy of the determination, and provide statistical modeling support for the experimental optimization.
7.Venetoclax with low-dose cytarabine for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: results from the Chinese cohort of a phase three randomized placebo-controlled trial
Yu HU ; Jie JIN ; Yu ZHANG ; Jianda HU ; Junmin LI ; Xudong WEI ; Sujun GAO ; Jiuhong ZHA ; Qi JIANG ; Jun WU ; Wellington MENDES ; H. Andrew WEI ; Jianxiang WANG
Chinese Journal of Hematology 2021;42(4):288-294
Objective:To investigate the safety and efficacy of venetoclax with low-dose cytarabine (LDAC) in Chinese patients with acute myeloid leukemia (AML) who are unable to tolerate intensive induction chemotherapy.Methods:Adults ≥ 18 years with newly diagnosed AML who were ineligible for intensive chemotherapy were enrolled in this international, randomized, double-blind, placebo-controlled trial. Globally, patients ( n=211) were randomized 2∶1 to either venetoclax with LDAC or placebo with LDAC in 28-d cycles, with LDAC on days 1-10. The primary endpoint was OS; the secondary endpoints included response rates, event-free survival, and adverse events. Results:A total of 15 Chinese patients were enrolled (venetoclax arm, n=9; placebo arm, n=6) . The median age was 72 years (range, 61-86) . For the primary analysis, the venetoclax arm provided a 38% reduction in death risk compared with the placebo[hazard ratio ( HR) , 0.62 (95% CI 0.12-3.07) ]. An unplanned analysis with an additional 6 months of follow-up demonstrated a median OS of 9.0 months for venetoclax compared with 4.1 months for placebo. The complete remission (CR) rates with CR with incomplete blood count recovery (CRi) were 3/9 (33%) and 0/6 (0%) , respectively. The most common non-hematologic adverse effects (venetoclax vs placebo) were hypokalemia[5/9 (56%) vs 4/6 (67%) ], vomiting[4/9 (44%) vs 3/6 (50%) ], constipation[2/9 (22%) vs 4/6 (67%) ], and hypoalbuminemia[1/9 (11%) vs 4/6 (67%) ]. Conclusion:Venetoclax with LDAC demonstrated meaningful efficacy and a manageable safety profile in Chinese patients consistent with the observations from the global VIALE-C population, making it an important treatment option for patients with newly diagnosed AML who are otherwise ineligible for intensive chemotherapy.
8.A systematic review of methodology in clinical trial-based health economics study with cost-effectiveness ratio for nutritional drug in T3 transfer of translational medicine
Zhuo LI ; Sheng HAN ; Zhuming JIANG ; Hai FANG ; Yang WANG ; Jiuhong WU ; Hui ZHANG ; Yan WANG ; Xiaomeng LI ; Xianna ZHANG ; Kang YU ; Weiming KANG ; Wei LI
Chinese Journal of Clinical Nutrition 2020;28(2):65-71
Objective:To systematically review the methodology in clinical trial-based health economics study with cost-effectiveness ratio for nutritional drug.Methods:The literature on health economics study for nutritional drug was retrieved from PubMed and Wanfang Medical Network by October 2019. The literature was selected according to inclusion and exclusion criteria, and was assessed using the Cochrane Risk Bias Assessment Tool and Newcastle-Ottawa Scale. Its methodology such as participants and grouping, confounding factors, research perspective, cost accounting, health outcomes and health economics analysis methods, sensitivity analysis, etc, was systematically reviewed as well.Results:Four target literatures were included in this study. The participants were from gastroenterology, gastrointestinal surgery, etc. Random grouping, regression, propensity score matching method, etc, were used to control confounding factors. The research perspective needed to be clear according to the principle of health economics study. The present literatures focused on "direct medical costs" , and calculated cost-effectiveness ratio or incremental cost-effectiveness ratio to evaluate the economics of medical interventions.Conclusion:The evidence of high-quality health economics research in parenteral and enteral nutrition area in China needs to be promoted, especially in the control of confounding factors, the choice of research perspective and sensitivity analysis, which are supposed to be explored by multidisciplinary research teams in practice.
9.Investigation of Risk Factors of Stroke in Community Residents Aged 40 years and Above
Jiuhong WU ; Donghua ZHANG ; Zhe LI ; Xiaohong WU ; Ying PENG
Modern Hospital 2018;18(5):688-689,692
To understand and master the distribution of risk factors of stroke in community residents aged 40 and above in Xiaogan city, to provide reference basis for the targeted development of stroke prevention and control. Methods Adopting the method of cluster sampling, 1780 community residents aged 40 or higher, using the unified " stroke risk groups and intervention project risk assessment chart" issued by the national health commission, a questionnaire survey was conducted to meet eligibility criteria, physical testing and laboratory examination. Results Of the 1 274 people who were assessed as high risk of stroke, 595 men, 679 women and 8 risk factors were among the top three of the patients with high blood pressure, obesity and blood lipids, 81. 5 percent, 61. 1 percent and 50. 2 percent respectively. The risk factors for ages 50~59 and 60~69 were more significant than those of other age groups. Conclusion The risk factors of high-risk groups were at a high level, and the distribution of risk factors was statistically significant (P<0. 05). We should aim to make healthy education for high-risk groups in the community, actively control risk factors and reduce the incidence of stroke.
10.Quality Standard Improvement for Compound Huanghuai Tablets
Jun LI ; Dong WANG ; Limei ZHANG ; Yang CHU ; Cheng PENG ; Jiuhong LIU ; Yan GUO
China Pharmacist 2017;20(12):2251-2254
Objective:To improve the quality standard for compound Huanghuai tablets. Methods: The main components of the preparation including Flos Sophorae Immaturus, Radix Scutellariae Baicalensis, Radix Paeoniae Rubra, Radix et Rhizoma Rhei Palma-ti, Rhizoma Imperatae, Caulis Spatholobi, Semen Coicis and Spica Prunellae Vulgaris were identified by TLC qualitatively. The content of rutin in Flos Sophorae Immaturus was determined by HPLC. A DIKMA? Spursil C18 (250 mm × 4. 6 mm, 5 μm) column was used with methanol-0. 2% phosphoric acid solution (45:55) as the mobile phase. The flow rate was 1. 0 ml·min-1 , the detection wave-length was set at 350 nm, the column temperature was maintained at 25℃, and the injection volume was 20μl. Results:The spots in TLC were clear without any interference. The calibration curve was linear within the range of 0. 0116-0. 1859 mg · ml-1 ( r =0. 9999) for rutin. The average recovery was 98. 93% (RSD=1. 14%,n=6). Conclusion: The improved quality standard is sim-ple, specific and reproducible, which can be used for the quality control of compound Huanghuai tablets.


Result Analysis
Print
Save
E-mail